v3.26.1
SCHEDULE OF COMMON STOCK OUTSTANDING (Details) (Parenthetical) - USD ($)
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Restricted Stock Units (RSUs) [Member]    
Class of Stock [Line Items]    
Grant date fair value $ 287,008 $ 7,505,400
Fair value price per share $ 5.15 $ 10.51
Number of RSUs vested [1] 82,000 749,864
Number of RSUs forfeited [2] 13,750 371,709
Number of RSUs cancelled [3] 338,476 60,000
Restricted Stock Units (RSUs) [Member] | Immediately Vested [Member]    
Class of Stock [Line Items]    
Number of RSUs vested 5,750 390,997
Restricted Stock Units (RSUs) [Member] | Immediately Vested [Member] | Neves Project [Member]    
Class of Stock [Line Items]    
Number of RSUs vested   170,799
Restricted Stock Units (RSUs) [Member] | Time-based Vesting Over Period [Member]    
Class of Stock [Line Items]    
Number of RSUs vested 50,000 87,326
Common Stock [Member]    
Class of Stock [Line Items]    
Common stock options issued 439,996 [4] 429,996 [5]
Grant date fair value $ 3,066,772  
Common stock options exercised 409,996 [6] 399,996 [7]
Weighted average exercise price, exercised $ 0.0075 [6] $ 0.0075 [7]
Common shares issued 409,996 399,996
Issuance of common stock in connection with sales made under private offerings, shares 10,127,566 2,062,973
Common Stock [Member] | Restricted Stock Units (RSUs) [Member]    
Class of Stock [Line Items]    
Issuance of common stock in connection with sales made under private offerings, shares 82,000 749,864
Common Stock [Member] | Restricted Stock Units (RSUs) [Member] | Minimum [Member]    
Class of Stock [Line Items]    
Fair value price per share   $ 13.50
Common Stock [Member] | Restricted Stock Units (RSUs) [Member] | Maximum [Member]    
Class of Stock [Line Items]    
Fair value price per share   $ 65.00
Common Stock [Member] | Restricted Stock Units (RSUs) [Member] | Immediately Vested [Member]    
Class of Stock [Line Items]    
Number of RSUs vested   65,000
Common Stock Option [Member]    
Class of Stock [Line Items]    
Common stock options exercised 409,996 399,996
Weighted average exercise price, exercised $ 0.0075 $ 0.0075
Cash proceeds $ 3,116 $ 2,999
Issuance of common stock in connection with sales made under private offerings, shares   399,996
[1] In the twelve months ended December 31, 2025, 82,000 RSUs vested and were settled through the issuance of 82,000 shares of common stock. In the twelve months ended December 31, 2024, 749,864 RSUs vested and were settled through the issuance of 749,864 shares of common stock.
[2] In the twelve months ended December 31, 2025, 13,750 RSUs (371,709 RSUs in 2024) were forfeited upon termination of employment and service agreements with former executives and consultants.
[3] In the twelve months ended December 31, 2025, 338,476 RSUs (60,000 RSUs in 2024) were cancelled without vesting because the performance conditions for vesting were not met.
[4] In the year ended December 31, 2025, 439,996 common stock options were issued with a grant date fair value of $ 3,066,772.
[5] In the year ended December 31, 2024, 429,996 common stock options were issued with a grant date fair value of $13,410,147.
[6] In the year ended December 31, 2025, common stock option holders exercised a total 409,996 options at a weighted average exercise price of $0,0075 to purchase our common stock. The exercises were paid for with $3,116 in cash proceeds to us. As a result of the options exercised, we issued 409,996 shares of common stock.
[7] In the year ended December 31, 2024, common stock option holders exercised a total 399,996 options at a weighted average exercise price of $0,0075 to purchase 399,996 shares of our common stock. The exercises were paid for with $2,999 in cash proceeds to us. As a result of the options exercised, we issued 399,996 shares of common stock.